View of Harnessing genomic profiling for precision breast cancer therapies: Advances in HER2-targeted treatments, PARP inhibitors for BRCA mutations, and insights from clinical trials

Return to Article Details Harnessing genomic profiling for precision breast cancer therapies: Advances in HER2-targeted treatments, PARP inhibitors for BRCA mutations, and insights from clinical trials Download Download PDF